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Abstract
Background: Palutop+4 (All. Diag, Strasbourg, France), a four-band malaria rapid diagnostic test
(malaria RDT) targeting the histidine-rich protein 2 (HRP-2), Plasmodium vivax-specific parasite
lactate dehydrogenase (Pv-pLDH) and pan Plasmodium-specific pLDH (pan-pLDH) was evaluated in
a non-endemic setting on stored whole blood samples from international travellers suspected of
malaria.
Methods:  Microscopy corrected by PCR was the reference method. Samples include those
infected by Plasmodium falciparum (n = 323), Plasmodium vivax (n = 97), Plasmodium ovale (n = 73)
and Plasmodium malariae (n = 25) and 95 malaria negative samples.
Results: The sensitivities for the diagnosis of P. falciparum, P. vivax, P. malariae and P. ovale were
85.1%, 66.0%, 32.0% and 5.5%. Sensitivities increased at higher parasite densities and reached 90.0%
for P. falciparum >100/μl and 83.8% for P. vivax > 500/μl. Fourteen P. falciparum samples reacted
with the Pv-pLDH line, one P. vivax sample with the HRP-2 line, and respectively two and four P.
ovale and P. malariae samples reacted with the HRP-2 line. Two negative samples gave a signal with
the HRP-2 line. Faint and weak line intensities were observed for 129/289 (44.6%) HRP-2 lines in
P. falciparum samples, for 50/64 (78.1%) Pv-pLDH lines in P. vivax samples and for 9/13 (69.2%) pan-
pLDH lines in P. ovale and P. malariae samples combined. Inter-observer reliabilities for positive and
negative readings were excellent for the HRP-2 and Pv-pLDH lines (overall agreement > 92.0% and
kappa-values for each pair of readers ≥ 0.88), and good for the pan-pLDH line (85.5% overall
agreement and kappa-values ≥ 0.74).
Conclusions: Palutop+4 performed moderately for the detection of P. falciparum and P. vivax, but
sensitivities were lower than those of three-band malaria RDTs.
Background
Malaria is a widespread and life-threatening disease. Each
year, 10,000 malaria cases are reported among returned
international travellers, and the real number of cases is
estimated at 30,000 [1]. Prompt diagnosis is essential for
the treatment and outcome, and malaria rapid diagnostic
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tests (malaria RDTs) may be of help to non-experienced
laboratory staff in non-endemic settings [2,3].
Malaria RDTs are immunochromatographic tests targeting
specific antigens of one or more Plasmodium  species.
Malaria RDTs are available as strips or cassettes, and dis-
play visible cherry-red to purple coloured control and test
lines. The initially developed two-band malaria RDTs had,
besides a control line, a Plasmodium falciparum-specific
line targeting histidine-rich protein-2 (HRP-2) or P. falci-
parum-specific parasite lactate dehydrogenase (Pf-pLDH).
Later developed three-band malaria RDTs additionally
detected an antigen common to the four main Plasmodium
species, such as aldolase or the pan Plasmodium-specific
pLDH (pan-pLDH). In addition, a few four band malaria
RDTs are on the market, such as Palutop+4 (All. Diag,
Strasbourg, France). This malaria RDT detects three anti-
gens: P. falciparum-specific HRP-2, Plasmodium vivax-spe-
cific pLDH (Pv-pLDH) and pan-pLDH. Four-band
malaria RDTs may distinguish between infections with P.
falciparum, P. vivax or another Plasmodium species and,
therefore, the intended field of application includes non-
endemic settings such as travel clinics. In this study, Palu-
top+4 was evaluated on stored blood samples of returned
international travellers.
Methods
Study design
In this retrospective study, Palutop+4 was evaluated with
a collection of stored samples obtained from interna-
tional travellers. Tests were carried out in the reference
laboratory of the Institute of Tropical Medicine (ITM) in
Antwerp, Belgium. The study design was in compliance
with the STARD guidelines for presentation of diagnostic
studies [4].
Patients and samples
Samples were selected from a collection of EDTA-blood
samples stored at -70°C and obtained from patients pre-
senting at the outpatient clinic of ITM. The patients were
international travellers and, to a lesser extent, immigrants
returning from visits to their native countries. In addition,
samples sent by Belgian laboratories to ITM in the scope
of the national reference function were included. The 530
samples collected at ITM, were aliquoted and frozen at -
70°C the day of collection. Between collection and stor-
age at -70°C, the samples remained for a maximum of 10
hours at ambient temperatures below 25°C. The 83 sam-
ples submitted by Belgian laboratories to ITM for second
opinion and confirmation were sent by mail and had
been exposed to ambient temperature for the period of
shipment, which was generally less than 24 hours and
ranged to a maximum of 48 hours. The delays of ship-
ment and processing before storage at -70°C had been
validated before and were compliant with routine labora-
tory procedures. In addition, samples from symptomatic
patients without malaria parasites (as tested with micros-
copy and polymerase chain reaction (PCR)) were
included.
Reference method
Microscopy, corrected by PCR, was used as the reference
method. Standard microscopy including determination of
parasite density was performed [5]. Malaria diagnosis at
Central Laboratory of Clinical Biology is accredited in
accordance with the requirements of the ISO 15189:2007
norm. The laboratory technicians have received a detailed
training and their performance and agreement are moni-
tored by participation to internal and external quality con-
trol assessments. As a standard procedure, all slides with
Plasmodium  spp. are confirmed by a second blinded
microscopist, as well as those slides that show results dif-
ferent from those obtained by RDTs and PCR. PCR analy-
sis was performed on all discordant samples, with a
species-specific real-time PCR as described previously [5].
Test platform
Palutop+4 is a lateral flow immunochromatographic
malaria RDT in a cassette format. Four lines are present, a
control line which indicates whether the test is valid, a
HRP-2 line, a Pv-pLDH line and a pan-pLDH line. Accord-
ing to the manufacturer's instructions, Palutop+4 can
detect P. falciparum, P. vivax, Plasmodium ovale and Plasmo-
dium malariae. Further it can distinguish between P. falci-
parum (unique HRP-2 line visible), P. vivax (unique Pv-
pLDH line visible), the other two Plasmodium  species
(unique pan-pLDH line visible) or mixed Plasmodium
infections (all other combinations of test lines). For the
evaluation, test kits of two different lot numbers were
used, 91055 and 91057. Test kits were stored at a dry place
between 18°C and 30°C.
Test procedure
Tests were performed according to the instructions of the
manufacturer except that samples (5 μl) where loaded
with a transfer pipette (Finnpipette, Helsinki, Finland)
instead of the plastic loop supplied. In case the control
line did not appear, the result was interpreted as invalid
and the test was repeated. Test lines were scored for inten-
sity as negative (no line visible), faint (barely visible line),
weak (paler than the control line), medium (equal to the
control line) or strong (stronger than the control line) [5].
Readings were performed 15 minutes after application of
the sample and diluent, by three blinded observers. The
results of the readings were based on consensus agree-
ment, which means that a positive result was defined as a
result read positive by at least two out of three different
observers. Inter-reader reliabilities were assessed for posi-Malaria Journal 2009, 8:293 http://www.malariajournal.com/content/8/1/293
Page 3 of 8
(page number not for citation purposes)
tive and negative readings as well as for the intensity read-
ings. To assess reproducibility, a panel of 16 samples
(including four P. falciparum, four P. vivax, four P. ovale
and four P. malariae samples) was tested on five successive
occasions.
Statistical analysis
Samples infected with P. falciparum, P. vivax and the two
other Plasmodium species were considered separately. For
P. falciparum, samples with pure gametocytaemia were
included among the positive samples. Tables 1, 2 and 3
list the definitions used for calculation of test characteris-
tics for P. falciparum, P. vivax and the two other Plasmo-
dium species respectively. Sensitivity and specificity were
calculated with 95% confidence intervals (CI) and differ-
ences were tested for significance using the Yates chi-
square test or, when this was not possible, the Fisher exact
probability test. A p-value of < 0.05 was considered signif-
icant. Reliabilities for positive and negative readings and
line intensities were calculated as percentage agreements
for all three readers and kappa values for each pair of read-
ers. Associations between line intensity readings and par-
asite densities were assessed for strength of association
with Cramer's V for categorical variables.
Duration of storage
To examine the effect of the duration of storage on the test
performance, the sensitivity of samples obtained between
1995 and 2000 was compared with those obtained
between 2001 and 2008.
Ease of use
Three experienced laboratory technicians scored the ease
of use of Palutop+4 test and the clarity of manufacturer's
instructions with a standardized list [5].
Ethical review
The study was reviewed and approved by the Institutional
Review Board of ITM and by the Ethical Committee of
Antwerp University, Belgium.
Results
Sample collection
A total of 613 samples was selected,. They had been col-
lected from December 1995 to August 2008. According to
microscopy and after correction by PCR analysis, 323 of
these samples were positive for P. falciparum, 97 for P.
vivax, 73 for P. ovale and 25 for P. malariae. In addition, 95
microscopic and PCR negative samples were included.
The majority (270/323) of P. falciparum infections was
acquired in Africa. They were obtained from 613 patients,
with a male-to-female ratio of 2.07:1, and median age of
36.5 years (range 1 - 84 years). Only a minority (nine
patients, 1.5%) were children less than five years old.
Invalid test results
One of the 613 samples gave an invalid result at initial
testing. Upon repetition, the test performed well.
Sensitivity, specificity and species mismatch
RDTs were performed between November and December
2008. Table 4 lists the results of the three test lines and
Table 5 lists the sensitivities for the different species and
parasite densities. For the detection of P. falciparum, the
overall sensitivity was 85.1% and was related to parasite
densities, with values at parasite densities > 100/μl which
were significantly higher as compared to those ≤ 100/μl
(90.0% versus 67.9% respectively, p < 0.001). For the
detection of P. vivax, the sensitivity was 66.0%, with
higher values above and lower values below the parasite
density breakpoint of 500/μl (83.8% versus 24.1%, p <
0.001). The sensitivities for the detection of P. malariae
and P. ovale were 32.0% and 5.5% respectively. The differ-
ences between parasite densities below and above 500/μl
did not reach statistical significance. The specificities for P.
falciparum, P. vivax and P. ovale/P. malariae were 96.9%
(94.0%-98.5%), 100% (99.1%-100%) and 100%
(99.1%-100%) respectively. The two malaria negative
patients with a false positive test result (Table 4) did not
have a recent history of malaria. Species mismatch was
observed in 21/518 Plasmodium-positive samples (4.1%,
Table 4): fourteen P. falciparum samples reacted with all
Table 1: Interpretation of test results for Palutop+4 for the detection of P. falciparum*
Test Line(s) visible Species
P. falciparum P. vivax, P. ovale, P. malariae or no 
parasites detected
Only HRP-2 or HRP-2 + pan-pLDH True positive False positive or species-mismatch†
None or HRP-2 + Pv-pLDH or HRP-2 + Pv-pLDH + pan-
pLDH or Only Pv-pLDH or Pv-pLDH + pan-pLDH or Only 
pan-pLDH
False negative or species-mismatch‡ True negative
†Non-falciparum species diagnosed as P. falciparum
‡P. falciparum diagnosed as non-falciparum species or a mixed Plasmodium spp. infectionMalaria Journal 2009, 8:293 http://www.malariajournal.com/content/8/1/293
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three test lines, one P. vivax sample reacted exclusively
with the HRP-2 line, and respectively two and four P. ovale
and P. malariae samples reacted with the HRP-2 line. In
the case of P. falciparum, cross-reactions with the Pv-pLDH
line occurred more frequently at parasite densities of ≥
100,000/μl compared to lower parasite densities (9/61
versus 5/262, p < 0.001). There was no relation between
the duration of storage of the samples and the sensitivity,
specificity and line intensities of the test.
Line intensities
For P. falciparum samples, 129/289 (44.6%) HRP-2 read-
ings gave faint or weak line intensities. For P. vivax sam-
ples, faint and weak line intensities accounted for 78.1%
(50/64) positive Pv-pLDH line readings, as well as for all
(n = 50) positive pan-pLDH line readings. For the P. ovale
and P. malariae samples combined, two and seven out of
13 positive pan-pLDH readings were faint and weak
respectively, the remaining four showed medium line
intensities. Line intensities for the HRP-2 and pan-pLDH
lines were related to parasite densities (HRP-2: V = 0.568,
p < 0.001; Pv-pLDH: V = 0.293, p = 0.14; pan-pLDH: V =
0.397, p < 0.001).
Of interest is that in the case of positive P. falciparum sam-
ples, the unique presence of a HRP-2 line pointed in most
cases (90.5%, 115/127 samples) to a parasite density
below 1000/μl. The co-presence of both HRP-2 and pan-
pLDH lines predicted parasite densities above 1000/μl in
115/148 (77.7%) of samples.
Inter-reader reliability and reproducibility
For the HRP-2 line and the Pv-pLDH line, the inter-reader
reliability for positive and negative test results was excel-
lent: for the HRP-2 line, there was 92.0% agreement
between the three readers and kappa values between the
three pairs of readers were 0.89, 0.88 and 0.88. For the Pv-
pLDH line, overall agreement was 96.4%, and kappa val-
ues were 0.91, 0.88 and 0.90. The inter-reader reliability
for the pan-pLDH line was lower, with 85.5% overall
agreement and kappa values of 0.74, 0.76 and 0.88 for the
three pairs of readers.
For the line intensity results, the overall agreement for the
HRP-2 line was 69.0% with kappa values of 0.67, 0.72,
and 0.67 for the three pairs of readers. For the Pv-pLDH
line intensity, the overall agreement between the three
readers was 91.4% with kappa values of 0.81, 0.72 and
0.73 for the three pairs of readers. For the pan-pLDH line
intensity, the overall agreement between the three readers
was 71.1% with kappa values of 0.63, 0.66 and 0.70 for
the three pairs of readers.
Test results (positive or negative) and line intensity read-
ings were reproducible. Consistent test results upon five
test occasions were obtained for 12 out of 16 samples.
From the four remaining samples, three and one had con-
sistent results upon four and three occasions respectively.
These four samples included three P. malariae samples
that showed positive and negative pan-pLDH lines upon
successive testing and a single P. falciparum sample that
Table 2: Interpretation of test results for Palutop+4 for the detection of P. vivax
Species
Test Line(s) visible P. vivax P. falciparum, P. ovale, P. malariae or no 
parasites detected
Only Pv-pLDH or Pv-PLDH + pan-pLDH True positive False positive or species-mismatch†
None or Only HRP-2 or HRP-2 + Pv-pLDH or HRP-2 + 
pan-pLDH or HRP-2 + Pv-pLDH + pan-pLDH or Only 
pan-pLDH
False negative or species-mismatch‡ True negative
†Non-vivax species diagnosed as P. vivax
‡P. vivax diagnosed as non-vivax species or a mixed Plasmodium spp. Infection
Table 3: Interpretation of test results of Palutop+4 for the detection of P. ovale and P. malariae
Test Line(s) visible Species
P. ovale or P. malariae P. falciparum, P. vivax or no parasites detected
Only pan-pLDH True positive False positive or species-mismatch†
Any other possibility except "only pan-pLDH" False negative or species-mismatch‡ True negative
†P. falciparum or P. vivax diagnosed as P. ovale or P. malariae
‡P. ovale or P. malariae diagnosed as P. falciparum or P. vivax or a mixed infection with one of these Plasmodium spp.Malaria Journal 2009, 8:293 http://www.malariajournal.com/content/8/1/293
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showed an additional Pv-pLDH line on a single test occa-
sion. All inconsistent results for line intensity readings
had discordances only within one category of difference
in line intensity.
Duration of storage
There was no significant difference between test sensitivi-
ties of samples that had been stored for long versus
shorter periods, for any of the four Plasmodium species
(Table 6).
Ease of use
Palutop+4 was scored as easy to use and practical, and the
instructions were scored as clear and simple to perform by
all three technicians. However, in roughly one third of
samples, the clearance of the test strip was not optimal
Table 4: Test results of all samples (n = 613)
Samples HRP-2 line positive HRP-2 line negative
Pv-LDH line positive Pv-pLDH line negative Pv-LDH line positive Pv-pLDH line negative
pan-pLDH 
line 
positive
pan-pLDH 
line 
negative
pan-pLDH 
line
 positive
pan-pLDH 
line 
negative
pan-pLDH 
line 
positive
pan-pLDH 
line 
negative
pan-pLDH 
line 
positive
pan-pLDH 
line 
negative
P. 
falciparum
(n = 323)
14† - 148 127 - - - 34
P. vivax
(n = 97)
- - - 1† 50 14 - 32
P. ovale
(n = 73)
--- 2 † --4 6 7
P. malariae
(n = 25)
- - 1† 3† - - 8 13
Negative
(n = 95)
---2--- 9 3
†Special mismatch
Table 5: Sensitivity of Palutop+4 for the detection of all Plasmodium species related to parasite densities*
Species Numbers Correctly identified by Palutop+4† Sensitivity in % (95% CI)
All P. falciparum samples 323 275 85.1 (80.7-88.7)
Pure gametocytaemia 17 12 70.6 (44.0-88.6)
Parasite density 0-100/μl 56 38 67.9 (53.9-79.4)
Parasite density 101-1000/μl 116 103 88.8 (81.3-93.7)
Parasite density >1000/μl 134 122 91.0 (84.6-95.1)
Parasite density >100/μl 250 225 90.0 (85.4-93.3)
All P. vivax samples 97 64 66.0 (55.6-75.1)
Parasite density ≤ 500/μl 29 7 24.1 (11.0-43.9)
Parasite density >500/μl 68 57 83.8 (72.4-91.3)
All P. ovale samples 73 4 5.5 (1.8-14.2)
Parasite density ≤ 500/μl 36 0 0 (0-12.0)
Parasite density >500/μl 37 4 10.8 (3.5-26.4)
All P. malariae samples 25 8 32.0 (15.7-53.6)
Parasite density ≤ 500/μl 9 2 22.2 (3.9-59.8)
Parasite density >500/μl 16 6 37.5 (16.3-64.1)
†A P. falciparum sample generating a unique HRP-2 line or both HRP-2 and pan-pLDH lines or a P. vivax sample generating a unique Pv-pLDH line or 
both Pv-pLDH and pan-pLDH lines or a P. ovale or P. malariae sample generating a unique pan-pLDH lineMalaria Journal 2009, 8:293 http://www.malariajournal.com/content/8/1/293
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and the strip remained red-coloured after completion of
the test procedure.
Discussion
This retrospective study showed that Palutop+4 per-
formed moderately well for the detection of P. falciparum
and P. vivax and poorly for the detection of P. ovale and P.
malariae. Sensitivities for P. falciparum and P. vivax at the
parasite density breakpoints of 100/μl and 500/μl were
90.0% and 83.8%, respectively. Species mismatches
occurred in 4.1% of Plasmodium-positive samples. Test
results were reliable and reproducible and the test was
scored as practical.
For this study, several limitations should be considered.
For instance, its retrospective design impeded the possi-
bility to test patients for known causes of false positive test
results such as the presence of the rheumatoid factor [6].
Further, a transfer pipette was used instead of the test's
application loop, thereby biasing any test errors due to
volume error [7]. Likewise, tests were performed in a ref-
erence setting and results should not be extrapolated to
field settings [8]. Furthermore, the storage-time of the
samples could affect antigen stability [7], although in the
present study the samples were not exposed to repeated
thawing and freezing procedures. There were no signifi-
cant differences in sensitivities between samples that had
been stored for long versus short periods for any of the
four Plasmodium species. Other evaluations, including the
World Health Organization (WHO) Malaria RDT Evalua-
tion Programme, also used stored samples [9]. In addi-
tion, for HRP-2, a prospective study revealed similar
results between fresh and stored samples for HRP-2 detec-
tion: 125 samples were tested upon collection and after a
storage duration of one to three years they were tested
again. In only six of the 125 samples the results were dis-
cordant [10]. Finally, it should be noted that the present
study used stringent criteria for defining test characteris-
tics: as an example, the 14 P. falciparum samples that
showed both the HRP-2 line and the Pv-pLDH line were
scored as "species mismatches", although the error of
diagnosing a mixed P. falciparum -  P. vivax infection
instead of a pure P. falciparum infection can be considered
as a minor error. If these 14 results would have been
scored as correct, sensitivity would increase to 89.5%.
Although most papers on malaria RDTs do not describe in
detail the criteria for defining test characteristics, it can be
assumed that a previous study on Palutop+4 [11] scored
this minor species-mismatch as correct, thereby explain-
ing for the higher sensitivity.
The WHO list of malaria RDT manufacturers with ade-
quate evidence of good manufacturing practice published
online [12] actually includes seven four-band malaria
RDTs. Palutop+4 is the only test for which published eval-
uations are available. In an endemic field setting, Rakot-
onirina et al found sensitivities for Palutop+4 of 95.4%
and 94.2% for P. falciparum and P. vivax, respectively [11].
Unlike the present study, they did not include P. ovale or
P. malariae positive patients. The present study showed
sensitivities for P. falciparum and P. vivax which are lower
as compared to their findings: apart from the possibility of
a different definition of test characteristics discussed
above, these lower results may also be due to a higher
number of samples with low parasite densities and pure
gametocytaemia. Further the present study included a
higher amount of samples (323 versus 87 P. falciparum
samples and 97 versus 17 P. vivax samples), thereby gen-
erating smaller confidence intervals. As in the present
study, Rakotonirina et al also demonstrated species mis-
Table 6: Comparison of test sensitivities between samples that had been stored for long and short periods
Species Year Numbers Correctly identified by Palutop Sensitivity in %
(95% CI)
p =
P. falciparum 1995-2000 109 95 87,2 (79,1-92,5)
2001-2008 214 180 84,1 (78,4-88,6) 0,467
P. vivax 1995-2000 46 32 69,6 (54,1-81,8)
2001-2008 51 32 62,8 (48,1-75,5) 0,479
P. ovale 1995-2000 32 2 6,3 (1,1-22,2)
2001-2008 41 2 4,9 (0,8-17,8) 0,593
P. malariae 1995-2000 7 2 28,6 (5.1-69,7)
2001-2008 18 6 33,3 (14,4-58,8) 0,607Malaria Journal 2009, 8:293 http://www.malariajournal.com/content/8/1/293
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match for one out of 87 P. falciparum samples (diagnosed
as P. ovale or P. malariae) and two out of 17 P. vivax sam-
ples (one diagnosed as P. falciparum and one as P. ovale or
P. malariae) [11].
Compared to other malaria RDTs in a non-endemic set-
ting, Palutop+4 has a lower sensitivity for the detection of
P. falciparum: reported sensitivities for two- and three-
band malaria RDTs ranged from 87.5%-99.0% [13-18],
with one exception of 76.2% [19]. In addition, the present
study found the sensitivity of Palutop+4 at parasite densi-
ties above 100/μl to be lower than the 95% value recom-
mended by the WHO [20]. The sensitivity for the
detection of P. vivax (66.0%) is in line with other malaria
RDTs. For the pan-pLDH, sensitivities of 35.3%[20] and
62.0%-95.0% [13,15,17] and for the aldolase, sensitivities
of 46.0%-93.0% [15] have been reported. Studies in
endemic settings that evaluated a dedicated Pv-pLDH
two-band malaria RDT reported overall sensitivities of
96.4% and 93.4% [21,22], and in a comparable study
design in the Antwerp laboratory, this malaria RDT
showed an overall sensitivity of 88.0% for the diagnosis of
P. vivax [23]. For P. ovale and P. malariae, it is more diffi-
cult to make comparisons, as sensitivities vary a lot among
different studies, with values for pan-pLDH and aldolase
ranging from 36.0% to 95.0% and from 7.0% to 80.0%
respectively [13,15]. Part of the lower sensitivity of Palu-
top+4 for these species may be explained by the four-band
design: optimal conditions, such as the pH and ionic
strength of the diluent and coating of the nitrocellulose
strips, must be met for three different antigen-antibody
combinations, with an inevitable trade-off in test charac-
teristics for one or more of the target antigens. Regarding
species mismatches, cross-reactions of P. falciparum with
high parasite density and the Pv-pLDH line have been
described earlier [23]. Also, the number of P. malariae
cross-reactions with the HRP-2 line was similar to other
findings [5]. Cross-reactions for P. vivax or P. ovale are
rarely observed [24].
Although Palutop+4 proved to be reliable and reproduci-
ble, most of the test line intensities, in particular those for
Pv-pLDH and pan-pLDH, scored faint or weak. In addi-
tion, there was incomplete clearance of the test strips in
about one third of specimens. These two facts may inter-
fere with correct reading: misinterpretation of faint line
intensities as negative test results is a frequent pitfall for
inexperienced staff both in endemic and non-endemic
settings [17,25]. Although the unique presence of the
HRP-2 line and its co-presence with the pan-pLDH line
were indicative for the parasite density, this prediction
was not as strict and conclusive as observed in other
malaria RDTs [5,26].
Conclusions
In view of its theoretical ability to diagnose and differen-
tiate among at least three of the four common Plasmodium
species, the intended use of Palutop+4 is in non-endemic
settings. However, the lower sensitivities of Palutop+4 for
the P. ovale and P. malariae species must be taken into
account and compared to three-band malaria RDTs. The
four-band design tends to have a lower sensitivity for the
detection of P. falciparum and P. vivax, even at higher par-
asite densities. Further improvement of test conditions
may favour the use of four-band malaria RDTs in the
future.
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